T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL.

Titel:: T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL.
Dokumenttyp:: Meeting Abstract
Autor(en):: Hopfinger, G; Kandler, G; Koller, E; Schmitt, B; Aul, C; Frickhofen, N; Grabenhorst, U; Herold, M; Jaeger, U; Marquart, F; Busch, R; Hallek, M
Zeitschriftentitel:: Blood
Jahr:: 2003
Band / Volume:: 102
Heft / Issue:: 11
Seitenangaben Beitrag:: 674A-674A
Sprache:: eng
Print-ISSN:: 0006-4971
TUM Einrichtung:: Institut für Medizinische Statistik und Epidemiologie
BibTeX

Vorkommen: